autismo y vacunacion.pdf
TRANSCRIPT
-
7/29/2019 autismo y vacunacion.pdf
1/15
This article was downloaded by: [186.105.153.131]On: 25 March 2013, At: 17:37Publisher: Taylor & FrancisInforma Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House37-41 Mortimer Street, London W1T 3JH, UK
Journal of Toxicology and Envi ronmental Healt h, PartA: Current Issues
Publ icat i on detai ls, including inst ruct ions for authors and subscr ipt ion inform ation:h t t p : / / w w w . t an df o nl i ne . co m / l oi / u t e h2 0
A Positive Association found between AutismPrevalence and Childhood Vaccination uptake acrossthe U.S. PopulationGayle DeLong
a
aDepartm ent of Economics and Finance, Baruch Col lege/ Cit y Universi t y of New York, New
York , New York , USAVersion of record first published: 26 May 2011.
To cite this art icle: Gayle DeLong (2011): A Posit ive Associat ion f ound bet ween Auti sm Prevalence and Childhood Vaccinat iuptake across the U.S. Population, Journal of Toxicology and Environmental Health, Part A: Current Issues, 74:14, 903-916
To link to t his art icle: ht t p : / / dx.do i .o rg/ 10.1080/ 15287394.2011.573736
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-and-conditions
This article may be used for research, teaching, and private study purposes. Any substantial or systematicreproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any form to
anyone is expressly forbidden.
The publisher does not give any warranty express or implied or make any representation that the contentswill be complete or accurate or up to date. The accuracy of any instructions, formulae, and drug doses shouldbe independently verified with primary sources. The publisher shall not be liable for any loss, actions, claims,proceedings, demand, or costs or damages whatsoever or howsoever caused arising directly or indirectly inconnection with or arising out of the use of this material.
http://dx.doi.org/10.1080/15287394.2011.573736http://www.tandfonline.com/page/terms-and-conditionshttp://dx.doi.org/10.1080/15287394.2011.573736http://www.tandfonline.com/loi/uteh20 -
7/29/2019 autismo y vacunacion.pdf
2/15
Journal of Toxicology a nd Environmental Health, Part A, 74:903916, 2011
Copyright Taylor & Francis Group, LLC
ISSN: 1528-7394 print / 1087-2620 online
DOI: 10.1080/15287394.2011.573736
A POSITIVE ASSOCIATION FOUND BETWEEN AUTISM PREVALENCEAND CHILDHOOD VACCINATION UPTAKE ACROSS THE U.S. POPULATION
Gayle DeLong
Department of Economics and Finance, Baruch College/City University of New York, New York,New York, USA
The reason for the rapid rise of autism in the United States that began in the 1990s isa mystery. Although individuals probably have a genetic predisposition to develop autism,researchers suspect that one or more environmental triggers are also needed. One of thosetriggers might be the battery of vaccinations that young children receive. Using regressionanalysis and controlling for family income and ethnicity, the relationship between the propor-tion of children who received the recommended vaccines by age 2 years and the prevalence of
autism (AUT) or speech or language impairment (SLI) in each U.S. state from 2001 and 2007was determined. A positive and statistically significant relationship was found: The higher theproportion of children receiving recommended vaccinations, the higher was the prevalenceof AUT or SLI. A 1% increase in vaccination was associated with an additional 680 childrenhaving AUT or SLI. Neither parental behavior nor access to care affected the results, sincevaccination proportions were not significantly related (statistically) to any other disability orto the number of pediatricians in a U.S. state. The results suggest that although mercury hasbeen removed from many vaccines, other culprits may link vaccines to autism. Further studyinto the relationship between vaccines and autism is warranted.
Autism is an urgent and growing public
health problem in the United States. The ill-ness impairs speech, language, social abilities,and behavior. In 1990, autism was considereda rare disease (Tebben 1990), but less than 2decades later autism affected an estimated 1 in91 U.S. children (Kogan et al. 2009). Althoughscientists generally agree that a genetic predis-position for autism exists (Rutter 2000), genesalone do not change quickly enough to createthe current epidemic. The recent explosion inthe prevalence of autism suggests the existenceof one or more environmental triggers (Blaxill
Received 29 October 2010; accepted 1 March 2011.This study includes data from the U.S. National Centers for Health Statistics (NCHS). Any analyses, interpretations, or conclusions
reached are the authors own and not those of the NCHS, which is responsible only for the initial data. The author is grateful to JosGarrofe Dorea, Anthony Mawson, Jonathan Rose, Paul Turner, and David Yermack as well as seminar participants at Baruch Collegeand two anonymous reviewers for thoughtful comments. Francis Donnelly provided invaluable assistance in creating the geographicinformation system graphic. The author has two children with pervasive development disorder, not otherwise specified. She has filed apetition in the U.S. Court of Federal Claims under the National Vaccine Injury Compensation Program for one of her children. The authoris on the board of directors and research committee of Sensible Action for Ending Mercury-Induced Neurological Disorders (SafeMinds).
Address correspondence to Gayle DeLong, PhD, Associate Professor, Department of Economics and Finance, Baruch College/CityUniversity of New York, One Bernard Baruch Way, Box B10-225, New York, NY 10010, USA. E-mail: [email protected]
2004). Could one of those triggers be the
battery of vaccinations given to young children?Chronic, negative reactions to vaccinationshave been recognized in both humans andanimals. In the late 19th Century, Burnett(1884/1960) described long-term negativeeffects such as eczema, diarrhea, and fatiguein some individuals who received a series ofsmallpox vaccinations. By the 1990s, veterinar-ians began to notice that some animals devel-oped chronic ailments such as autoimmunedisorders and seizures after being vaccinated(Smith 1995; Dodds 2001). In the early
903
-
7/29/2019 autismo y vacunacion.pdf
3/15
904 G. DELONG
2000s, vaccines were shown to be linked toautoimmune disorders and, possibly, autism inhumans (Shoenfeld and Aron-Maor 2000).
There are several reasons why vaccinesmay trigger autism. Certain vaccines containthimerosal, a preservative that is almost halfmercury (Hg) by weight, which was shown tobe associated with adverse effects includingautism. Nataf et al. (2006) found that childrenwith autism have higher levels of precopro-porphyrin, a biomarker for Hg toxicity, thanneurotypical children. This finding was con-firmed by Geier and Geier (2007) and Geieret al. (2009) in the United States, Austin andShandley (2008) in Australia, and Youn et al.(2010) in Korea. Thimerosal-containing hep-
atitis B shots were associated with delayedacquisitions of vital reflexes in baby macaques(Hewitson et al. 2010). Although thimerosalwas removed from many vaccines from 2000,it is still present in almost all influenza shotsas well as eight other U.S. vaccines givento children (Centers for Disease Control andPrevention 2010). In addition, the CDC beganin the early 2000s to encourage the inoculationof pregnant women and children aged 6 to 23months against influenza (Centers for DiseaseControl and Prevention 2001; 2002). Given
the increased use of influenza shots contain-ing thimerosal, childrens exposure to Hg viavaccines was likely increased in utero but notdecreased after fetuses were born, even thoughthimerosal was removed from other vaccines.
There are other possible links between vac-cines and autism besides Hg. Vaccines alsocontain the neurotoxin aluminum (Al) as wellas live viruses. The Al in vaccines has beenassociated with disorders in the central ner-vous system (Authier et al. 2001) as well aswith autism (Blaylock 2008). Combining Hg
and Al magnifies the toxicity of each (Haley2005). Both metals also are known to suppressthe immune system (Havarinasab et al. 2005);thus, a susceptible person may not be able tomount an effective immunological response tothe live viruses found in certain vaccines suchas the measlesmumpsrubella shot. Measles-containing vaccines stimulate the production ofcytokines that inflame and damage the brain,
possibly contributing to autism (Ashwood et al.2004; Vargas et al. 2005; Singh 2009).
Children with autism appear to have vul-nerabilities that their neurotypical peers do notpossess. Autistic children tend to exhibit higherlevels of oxidative stress and poorer methyla-tion, the process by which the body detoxifiesitself (James et al. 2004). This difficulty in detox-ifying could be associated with metals fromvaccines being sequestered in the brain andcausing neurological damage (Kern et al. 2007).Vaccines may also increase the oxidative stressof children with preexisting mitochondrial dys-functions to such an extent that the childrendevelop autism (Poling et al. 2006). In gen-eral, susceptibility to developing a neurological
disability after exposure to an environmentalinsult such as a vaccine depends on factors suchas a childs age at time of exposure, amountof exposure, genetic predisposition, and stress(Kern and Jones 2006).
Compounding these biological issues is thefact that the number of vaccinations recom-mended for U.S. children by age 2 years hasmore than tripled, from 8 vaccinations in 1983to 27 in 2010 (Centers for Disease Control andPrevention 1983; 2010). Although individualvaccines are tested for safety and efficacy, no
study has ever examined the safety of the entirevaccination schedule recommended for U.S.children by the CDC. Neither the short-termnor chronic interactions among all the vaccinesin a childs recommended schedule have everbeen tested.
Examining the relationship between theproportion of children who receive vaccina-tions and the prevalence of autism may provideinsights into whether autism is an adverse reac-tion to vaccinations. If an association betweenreceiving vaccinations and developing autism is
found to exist across geography and throughtime, further investigation into the hypothesisis warranted.
METHODS
In this study, the relationship betweenthe proportion of U.S. children who receiveda series of vaccinations recommended by
-
7/29/2019 autismo y vacunacion.pdf
4/15
ASSOCIATION BETWEEN AUTISM AND VACCINATION 905
the U.S. Centers for Disease Control andPrevention (CDC) by age 2 years and the preva-lence of autism in each U.S. state over time wasexamined.
Measures
Prevalence of autism To determine autismprevalence by U.S. state, the number of 8-year-old students classified with either (1) autismor (2) speech or language impairments (speechdisorders) was divided by the total numberof 8-year-olds in the state. The number ofchildren with disabilities came from the U.S.Department of Education, Office of SpecialEducation Programs (2007) and the total num-
ber of students came from the U.S. Departmentof Education, National Center for EducationStatistics. Although the diagnosis of autism isusually made when a child is 3 or 4 yearsold, some children are not diagnosed until theyare older. Children who receive a diagnosisof autism usually do so by the time they are8 years old. The category of speech or lan-guage impairments was included with autism,because these impairments are closely linkedto autism (Conti-Ramsden et al. 2006; De Fosseet al. 2004; Herbert et al. 2007).
Exposure to a recommended vaccinationseries Since 1994, the CDC has commis-sioned an annual survey to estimate vaccina-tion coverage in the United States for preschoolchildren. Surveyors at the National OpinionResearch Center (NORC) at the University ofChicago randomly call homes to find house-holds with children aged 19 to 35 months.When such a household is found, the inter-viewer asks which vaccinations the child hasreceived. If the parent or guardian agrees,NORC follows up the telephone interview
with a written survey to the vaccinationprovider. The survey reaches approximately30,000 households with children of the appro-priate age. The proportion of children in eachstate that receives the various vaccines recom-mended by the CDC is reported. Starting in1995, the CDC reports the percentage of youngchildren who have received the 4:3:1:3:3series of shots, which consists of at least four
doses of the diphtheria, tetanus, and pertussis(or diphtheria, tetanus, and acellular pertussis)vaccine, three doses of poliovirus vaccine, onedose of any measles-containing vaccine, threedoses of the Hib vaccine, and three doses ofhepatitis B vaccine. The results of this surveyas well as the follow-up verification from thevaccination provider are available to the pub-lic (Centers for Disease Control and Prevention,National Center for Health Statistics 2007).Since the possible magnification effect of thetoxins in vaccines is of interest as well asthe possible interactions between toxins andlive viruses, the proportion of children whoreceived the entire 4:3:1:3:3 series of vaccina-tions by the time they were 19 to 35 months
old was examined in this study.Children who are vaccinated at age 2 yearsmay not develop autism until they are older.To determine the prevalence of autism for aspecific cohort of children, the vaccinationdata from when the children were 2 years oldis compared with autism prevalence when theyare 8 years old. The relevant vaccination datafor children who were 8 years old in 2001 arethose from 1995, when the children were 2years old. For children who turned 8 years oldin 2002, the relevant vaccination data are from
1996, and so on. The earliest available datavaccination data from 1995were matchedwith autism prevalence up to 2007. Table 1shows the vaccination and autism/speechdisorder data by state for the various years inthis study.
Figure 1 shows the relationship betweenthe prevalence of 8-year-old children withautism or speech disorders by state in 2005and vaccination proportions 6 years earlier. Thedarker the shading of the state, the higher isthe proportion of children who received the
4:3:1:3:3 series of vaccinations by the timethey were 2 years old; the larger the cir-cle, the greater is the prevalence of autismor speech disorders. Groupings of data weredetermined using the Natural Breaks (Jenks)method in the Arc geographic information sys-tem (ArcGIS) software package (EnvironmentalSystem Research Institute Inc. 2009). The mappresents an ambiguous picture: Some states,
-
7/29/2019 autismo y vacunacion.pdf
5/15
TABLE
1.VaccinationRate(19
952001)andAUT/SLIPrevalence(20012007)byU.S.State
Vaxrate
AUT/SLI
Vaxrate
AUT/SLI
Vaxra
te
AUT/SLI
Vaxrate
AUT/SLI
Vaxrate
AUT/SLI
Vaxrate
AUT/SLI
Vax
rate
AUT/SLI
U.S.state
1995
2001
1996
2002
1997
2003
1998
2004
1999
2005
2000
2006
2001
2007
Alabama
45.8
4.6
65.2
4.4
76.5
4.4
74.2
4.5
74.1
4.7
76.1
4.6
79.1
4.5
Alaska
54.3
5.8
67.2
5.1
68.8
5.5
74.1
6.0
74.5
4.8
70.6
5.0
71.2
4.8
Arizona
51.2
3.8
61.8
4.1
62.0
4.1
69.0
4.8
67.3
5.2
67.2
5.4
68.1
6.2
Arkansas
53.6
4.8
61.4
4.8
74.8
5.0
65.9
5.3
70.4
5.8
67.1
6.3
69.1
5.9
California
57.7
4.5
65.8
4.6
67.1
4.6
69.8
4.6
70.5
4.6
72.3
4.7
72.6
4.6
Colorado
51.4
3.1
66.3
3.5
64.4
3.6
67.9
3.6
69.6
3.9
71.6
4.0
71.5
4.1
Connecticut
63.9
3.6
80.6
3.9
76.0
3.7
81.5
3.9
82.3
3.9
81.6
4.2
78.4
4.1
Delaware
54.7
3.3
73.5
3.2
68.3
3.3
68.0
3.6
69.0
3.1
66.2
2.1
68.9
N/A
DistrictofCoumbia
49.8
3.2
66.8
2.3
62.4
2.7
63.5
2.6
70.9
2.7
70.0
3.7
74.9
3.3
Florida
53.4
6.0
72.1
6.0
67.3
5.6
75.4
5.6
77.9
5.7
71.7
6.4
73.0
6.4
Georgia
61.7
5.2
76.9
5.5
72.9
5.7
75.7
5.9
77.9
5.9
77.7
5.9
78.5
5.7
Hawaii
66.2
2.0
74.4
1.8
73.2
1.7
73.0
1.4
79.2
1.3
72.8
1.4
70.8
1.0
Idaho
40.7
4.0
51.9
3.9
63.9
3.8
66.2
4.2
65.0
4.2
70.7
4.6
70.2
4.4
Illinois
57.2
5.6
64.9
5.6
67.4
5.6
73.7
5.5
72.0
5.5
71.2
5.7
72.7
5.6
Indiana
41.8
8.8
56.7
8.9
62.7
9.1
68.8
9.1
65.3
9.2
72.0
9.8
71.1
10.0
Iowa
47.7
1.6
70.3
2.5
71.0
2.1
78.1
2.2
78.9
2.2
82.5
2.1
78.6
2.0
Kansas
35.7
5.1
58.2
5.1
72.1
5.2
72.1
5.0
70.7
5.1
71.3
4.9
72.8
4.9
Kentucky
59.6
6.0
70.4
6.0
70.2
5.8
75.5
6.3
84.4
6.6
77.0
7.1
75.9
7.1
Louisiana
61.8
5.1
73.0
5.1
70.6
5.2
72.4
5.4
72.3
5.1
71.8
5.4
64.1
5.6
Maine
46.6
6.6
68.4
6.9
78.4
6.8
78.3
7.2
76.8
7.7
76.0
7.5
75.1
7.2
Maryland
59.2
4.5
64.9
4.7
73.7
4.8
72.3
4.6
72.7
4.5
75.4
4.7
73.4
4.6
Massachusetts
70.7
2.2
79.9
2.6
81.1
3.0
79.6
3.3
81.4
3.6
81.4
3.8
76.6
4.1
Michigan
46.7
5.1
66.2
5.5
69.3
5.5
73.9
5.7
70.9
5.9
73.7
6.2
70.0
6.2
Minnesota
41.2
4.0
63.2
4.3
63.7
4.4
73.1
4.5
78.5
4.8
82.4
4.8
76.3
5.1
Mississippi
38.1
6.2
68.1
6.4
70.8
6.6
79.5
6.2
79.0
6.2
75.9
6.7
80.2
6.8
Missouri
50.5
6.2
68.3
7.1
67.6
7.5
74.8
8.1
68.9
8.5
76.8
9.0
75.5
8.7
Montana
44.7
5.7
59.2
5.1
64.3
5.7
75.2
6.0
76.4
6.2
71.1
N/A
77.9
5.9
Nebraska
49.2
7.3
65.3
7.0
66.4
7.2
71.1
7.7
79.8
7.7
75.5
7.6
78.9
7.9
Nevade
55.9
4.0
61.9
4.0
65.5
4.2
70.4
3.9
68.5
4.3
69.1
5.0
68.1
5.1
NewHampshire
72.7
3.5
77.3
3.2
76.8
3.3
75.8
3.4
78.4
3.7
78.9
3.6
77.6
3.9
NewJersey
60.5
7.1
68.5
7.3
70.5
7.1
76.7
7.2
75.3
7.2
71.2
7.6
73.1
7.7
NewMexico
43.8
5.1
66.2
5.1
66.1
5.0
66.0
4.8
66.6
4.9
64.5
5.3
63.2
5.5
906
-
7/29/2019 autismo y vacunacion.pdf
6/15
NewYork
62.6
3.6
72.6
3.8
68.1
4.1
79.9
4.2
78.2
4.4
72.3
4.6
77.1
5.0
NorthCarolina
62.5
5.1
69.8
5.0
76.5
5.1
76.7
5.5
77.1
5.5
82.8
5.8
80.4
5.9
NorthDakota
65.7
6.5
71.9
6.8
73.2
6.8
73.0
7.3
76.3
6.5
80.3
6.9
78.7
6.7
Ohio
47.7
4.3
69.5
4.4
63.9
4.3
71.0
4.4
73.0
4.5
68.9
4.7
71.2
4.6
Oklahoma
42.3
5.6
59.0
6.1
65.0
5.9
70.3
5.9
70.4
6.5
68.3
7.0
70.0
6.7
Oregon
56.6
6.1
62.4
6.1
62.0
6.1
67.4
6.4
63.8
6.6
74.7
6.8
68.5
6.9
Pennsylvania
62.2
4.4
70.1
4.7
70.9
4.7
75.7
4.9
80.8
5.0
77.8
5.3
78.8
5.4
RhodeIsland
58.5
6.1
77.0
6.3
72.0
6.6
76.9
6.5
83.2
6.2
80.5
6.8
81.7
6.9
SouthCarolina
72.2
7.1
83.0
7.4
74.4
7.3
83.8
7.2
78.0
7.3
78.5
7.0
78.7
7.3
SouthDakota
27.5
6.5
62.0
7.1
67.0
7.5
66.1
7.7
76.9
7.6
73.6
7.9
76.5
8.7
Tennessee
57.8
5.3
72.3
5.4
71.3
5.4
73.5
5.3
70.0
5.5
76.8
5.9
79.7
6.0
Texas
52.4
4.0
62.5
4.1
65.3
4.2
63.7
4.2
64.8
4.2
63.5
4.3
69.7
4.3
Utah
43.7
4.7
53.4
4.8
53.7
4.9
64.8
5.4
65.8
5.2
68.2
5.7
66.1
6.6
Vermont
55.8
3.4
76.8
3.0
78.0
2.3
80.7
2.9
85.2
2.5
77.0
2.8
80.3
N/A
Virginia
52.8
4.2
68.3
4.5
66.6
4.6
75.1
4.6
74.9
4.7
70.7
4.9
74.9
4.7
Washington
57.0
4.1
68.5
4.0
66.6
4.0
68.8
4.1
67.1
4.2
72.5
4.3
71.2
4.4
W
Virginia
28.9
9.9
50.5
9.7
73.4
10.1
75.6
10.2
77.8
10.7
71.9
11.0
78.1
11.3
Wisconsin
53.1
4.2
67.1
4.4
70.9
4.7
70.6
4.9
78.6
5.1
74.2
5.7
79.5
6.0
Wyoming
18.9
6.9
48.0
6.8
69.2
7.6
75.4
8.1
81.5
8.2
78.2
8.7
74.3
10.0
Note.Vaxrate=
proportion
of2-year-olds(%)receiving4:3:1:3:3series
ofvaccinations6yearsearlier.AUT/SLI=prevalenceofautismorspeech/languageimpairment(%)inyear
indicated.N/A=
notavailable.
907
-
7/29/2019 autismo y vacunacion.pdf
7/15
908 G. DELONG
FIGURE 1. Vaccination (1999) and Autism or Speech Disorder (2005) by U.S. State (color figure available online).
such as Texas, have low vaccination rates andlow prevalence of autism, while other states,such as Indiana, have low vaccination rates
and a high prevalence of autism. Conversely,Wyoming has a high vaccination rate and highprevalence of autism, while Vermont has ahigh vaccination rate and low prevalence ofautism. Additionally, Figure 1 merely presentsa snapshot, based on prevalence data in 2005.More rigorous analysis is needed that includesseveral years of data, as well as variables tocontrol for influences other than the vaccineseries.
Controlling for family environment Familyincome and ethnicity may influence whether a
child receives a diagnosis of autism. More afflu-ent parents may be more prone to seek a diag-nosis (McAdoo and DeMyer 1977). Ethnicitymay be a factor in terms of the postula-tion that a deficiency in vitamin D is asso-ciated with autism: Dark-skinned people areknown to require more vitamin D and there-fore might be more prone to develop autism(Cannell 2008). For these reasons, variables
that measure household income and ethnicityare included.
To measure income, the median income
for a four-person family reported by the U.S.Census Bureau (2008) was used. The inflation-adjusted median income (using the year 2000as the base) for the year the child was born wasused. For example, the prevalence of autismor speech disorder for 8-year-olds in a par-ticular U.S. state in 2001 was matched withthe median income in that state from 1993.Ethnicity figures were derived directly from theCDCs National Immunization Survey. The sur-vey reported whether the child was Hispanic,
African American, white non-Hispanic, or
other. For each state and year, the percent-age of each ethnic group in the survey wasdetermined.
Statistical Analysis
To understand whether vaccination mightbe linked to autism, data on the prevalenceof autism or speech disorders between 2001
-
7/29/2019 autismo y vacunacion.pdf
8/15
ASSOCIATION BETWEEN AUTISM AND VACCINATION 909
and 2007 were matched with vaccinationrates between 1995 and 2001 for each U.S.state. Regression analysis determines how a 1%change in the vaccination rate influences thepercent change in the prevalence of autismor speech disorders (Lewis-Beck 1990). Thestatistical model used took into considerationthe unique characteristics of each state. Forexample, each state had a unique mixture ofpollution, which may have affected the preva-lence of autism (Palmer et al. 2006; 2009), yetsuch an effect was not included in this study.
A fixed-effects, within-group panel regression(Hall and Cummins 2005) controlled for theseunique yet undefined characteristics by deriv-ing a different starting point (intercept) for each
U.S. state. The 51 different interceptsone foreach U.S. state and the District of Columbiareflected the base level of autism or speechdisorders occurring in that state that werenot explained by the other independent vari-ables (vaccination rates, income, or ethnicity).The model then produced a single relation-ship between the independent variables andthe prevalence of autism or speech disorders.
Although each state started from a differentprevalence rate of autism or speech disorder,the relationships between the dependent vari-
able and independent variables was consideredthe same across state; a 1% change in vacci-nation rates was associated with the same per-cent change in prevalence of autism or speechdisorder across states. Similarly, the model con-trolled for the year in which an observationtook place. If autism awareness increased in aparticular year, the prevalence might also rise(Liu et al. 2010). To control for reasons thatoccur in a particular year, time dummy vari-ables for the year of observation were included:If an observation of prevalence occurred in
the year 2002, then the variable 2002 took avalue of 1 and the other year variables tooka value of 0. Heteroskedastic-robust standarderrors were calculated and used in determin-ing p values (Hall and Cummins 2005). Thestatistical package TSP 4.5 was used for theanalysis.
The model that results from the 7 yearsof prevalence data (years 2001 to 2007)
with control variables as well as time dummyvariables is:
Autism = a+ b1Vaccination+ b2Log(Income) + b3Hispanic+ b4African
American+ b5Other+ b62002+b72003+ b82004 + b92005+b102006 + b112007
If a combination of independent variablesperfectly predicts another independent vari-able, the model is said to suffer from per-fect multicollinearity and some coefficientswill be undefined (Lewis-Beck 1990). In thismodel, if the percentage of the populationin a U.S. state that was Hispanic, African
American, and other is known, then the per-centage of the population that was white,non-Hispanic might be determined with cer-tainty. Similarly, if the year of the prevalenceobservation was not between 2002 and 2007,then the year of the observation was 2001with certainty. Therefore, to obtain meaning-ful coefficients, the dummy variable for theyear 2001 as well as the percentage of white,non-Hispanic children were removed from themodel.
RESULTS
The results are reported in the first columnof Table 2. The association between receivingthe 4:3:1:3:3 series of vaccinations and theprevalence of autism or speech disorders is apositive and statistically significant 1.7%. Thiscoefficient represents the average change inthe prevalence of autism or speech disordersfor a 1% change in vaccination rates, hold-ing the other independent variables constant.This result holds both across geography and
over time. The results suggest that if a givenU.S. state has a 1% higher vaccination ratethan another U.S. state, then the state with thehigher vaccination rate might have, on average,a 1.7% higher prevalence of autism or speechdisorders. Further, if a given U.S. state decreasesits vaccination coverage by 1% from one yearto the next, prevalence of autism or speechdisorders may, on average, fall by 1.7%. If 100%
-
7/29/2019 autismo y vacunacion.pdf
9/15
TABLE
2.AnalysisofLearningDisabilities,UnitedStates,20012007,FixedEffe
ctsModel
Autismorspeech
orlanguage
impairment
Emotional
disturbance
Hearing
impairment
Me
ntal
retardation
Orthopedic
impairment
Otherhea
lth
impairment
Specificlearning
disability
Traumaticbrain
injury
Visual
impairment
Proportionof
children
receiving
4:3:1:3:3
vaccination
series
0.0166
(0.00)0.0010(0.31)
0.0026(0.70)
0.0
008(0.69)
0.0008(0.42)
0.0018(0.32)
0.0064
(0.09)
0.0006(0.17)
0.0003
(0.10)
Log(household
Income)
0.0029(0.70)
0.0006(0.72)
0.0081(0.31)
0.0
008(0.34)
0.0014(0.46)
0.0011(0.73)
0.0004(0.95)
0.0014
(0.01)
0.0001(0.71)
Hispanic(%)
0.0213(0.13)
0.0006(0.83)
0.0269
(0.06)
0.0
117
(0.00)
0.0042(0.20)
0.0029(0.56)
0.0061(0.72)
0.0008(0.41)
0.0005(0.29)
African
American,not
Hispanic(%)
0.0216(0.13)
0.0108(0.15)
0.0443(0.12)
0.0
053(0.97)
0.0073(0.19)
0.0055(0.29)
0.0231(0.23)
0.0001(0.90)
0.0001(0.79)
Other,not
Hispanic(%)
0.0208(0.41)
0.0124
(0.03)0.0074(0.64)
0.0
024(0.69)
0.0025(0.60)
0.0078(0.26)
0.0479
(0.01)
0.0009(0.77)
0.0013
(0.04)
AdjustedR2
.9636
.9358
.1803
.95
36
.7935
.9090
.9006
.9280
.5312
n
354
354
348
354
327
352
356
231
302
Note.Standarderrorsarehetero
skedastic-robustusingWhitesmethod.Timedummyvariablesincluded;pvaluesareinparentheses.Themaximumnumberofobservationsis357.Notevery
statereportseachdisabilityforeveryyearsothenumberofobservationscouldbelessthan357.Significanceindicatedas
()()p